Mitomycin C in combination with capecitabine or biweeklyhigh-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial-Reference-Cited by-同舟云学术

Mitomycin C in combination with capecitabine or biweeklyhigh-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial

Published:2004-03 Issue:3 Volume:15 Page:478-483
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Kornek G.V.,Schuell B.,Laengle F.,Gruenberger T.,Penz M.,Karall K.,Depisch D.,Lang F.,Scheithauer W.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/15/3/478/558111/mdh096.pdf

Reference33 articles.

1. Cancer statistics 2001;Greenlee;CA Cancer J Clin,2001

2. Biliary tract cancers;De Groen;N Engl J Med,1999

3. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary tract cancer;Glimelius;Ann Oncol,1996

4. The role of chemotherapy and radiation in the management of biliary cancer: a review of the literature;Hejna;Eur J Cancer,1998

5. Phase II trial of mitomycin C (MMC) in advanced gallbladder and biliary tree carcinoma: an EORTC gastrointestinal tract cancer cooperative group;Taal;Ann Oncol,1991

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Durable Response to Pembrolizumab and Lenvatinib in a Patient with Chemotherapy-refractory Cholangiocarcinoma;Archives of Cancer Science and Therapy;2024-07-15

2. Practice patterns in diagnostics, staging, and management strategies of gallbladder cancer among Nordic tertiary centers;Scandinavian Journal of Surgery;2023-06-28

3. Emerging Role of microRNA Dysregulation in Diagnosis and Prognosis of Extrahepatic Cholangiocarcinoma;Genes;2022-08-19

4. Liver Cancer Study Group of Japan Clinical Practice Guidelines for Intrahepatic Cholangiocarcinoma;Liver Cancer;2022

5. Gallbladder cancer: Historical treatment and new management options;World Journal of Gastrointestinal Oncology;2021-10-15